Marvin & Palmer Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$7.54M |
| 2 |
Intuitive Surgical
ISRG
|
+$5.48M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.69M |
| 4 |
Intercontinental Exchange
ICE
|
+$3.03M |
| 5 |
Brown & Brown
BRO
|
+$3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$5.32M |
| 2 |
Microsoft
MSFT
|
+$5.06M |
| 3 |
Ingersoll Rand
IR
|
+$4.68M |
| 4 |
Ameriprise Financial
AMP
|
+$4.29M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$4.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.54% |
| 2 | Industrials | 18.25% |
| 3 | Healthcare | 10% |
| 4 | Communication Services | 7.44% |
| 5 | Technology | 7.22% |
Similar funds
Marvin & Palmer Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Marvin & Palmer Associates held 44 positions worth $119M, up 22% from $97.7M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Marvin & Palmer Associates deployed $16M of net new capital in Q3 2024, opening 16 new positions and adding to 10 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 76,769 shares worth $7.58M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $567K trimmed.
- Marvin & Palmer Associates's largest Q3 2024 buy was State Street SPDR S&P Biotech ETF: 76,769 shares worth $7.58M.
- Marvin & Palmer Associates added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.94M increase.
- Marvin & Palmer Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $567K.
- Marvin & Palmer Associates fully exited Eaton in Q3 2024, selling an estimated $5.32M.
- Marvin & Palmer Associates's ten largest holdings make up 55% of its $119M portfolio in Q3 2024.
- Marvin & Palmer Associates opened 16 new positions and closed 12 in Q3 2024.
- Marvin & Palmer Associates's portfolio value rose 22% quarter-over-quarter to $119M.
Based on Marvin & Palmer Associates's 13F filing for Q3 2024, filed 13 Nov 2024.